Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ELCC 2018 banner

Media registration

ESMO welcomes media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card.Media representatives are required to observe and abide by the ELCC Media Policy which applies to all ESMO events.

To register for the event, please fill out the Media Registration Form

Complete the Media Registration Form

Media registration in advance is strongly recommended although on-site registration will still be possible. Further information for press representatives will be made available over the following weeks.

Please contact the ESMO Press Office for any additional questions.

ELCC 2018 programme and abstracts

For details about the ELCC 2018 programme and abstracts schedule, please click here.

Publication of accepted abstracts

All accepted abstracts will be published online only in the ELCC 2018 Abstract Book, as a supplement of the official IASLC journal, Journal of Thoracic Oncology.

Abstracts accepted for presentation during ELCC 2018 (Proffered Paper, Poster Discussion and Poster) and for publication in the ELCC 2018 Abstract Book, will be published online on the ELCC 2018 Website, at 12:00 CEST (Central European Summer Time) on 4 April 2018.

Late-breaking abstracts accepted for presentation during ELCC 2018 will be made public at the beginning of the scientific session during which they are presented.

ELCC 2018 press programme

All abstracts selected for the ELCC 2018 press programme, will be accompanied by a press release distributed accordingly with the following embargo lift:




Embargo lift (CEST)*


3-year survival and duration of response in randomized Phase II study of atezolizumab (atezo) vs docetaxel (doc) in 2L+ NSCLC (POPLAR)

Julien Mazières et al.

12 April 2018,


Patient-reported outcomes (PROs) in ALEX: a phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)

Maurice Pérol et al.

12 April 2018,


Impact of the continuity of nursing care delivered by a pivot nurse in oncology on improving satisfaction and quality of life of patients with advanced lung cancer

Elie Kassouf et al.

12 April 2018,

*Central European Summer Time

Third-party media activities

Media activities initiated by third parties during or in connection with ELCC 2018, including, but not limited to:

  • Meetings such as press conferences, media briefings, educational sessions for media representatives, as well as
  • PR activities, such as press releases, news, articles, interviews, etc.

are subject to the  ELCC Policy on Third-Party Media Activities. This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the conference.

Press events in or outside the congress centre but concomitant with/or during breaks of the scientific programme of ELCC 2018 are subject to ELCC Press Office approval.    Please submit your first request through the following form.

Blackout times

During Blackout times any media activity initiated by third parties is not allowed.



Wednesday, 11 April 2018


Thursday, 12 April 2018


Friday, 13 April 2018


Saturday, 14 April 2018



ESMO Press Office

E-mail: media@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings